Two Democrats in Congress — Rep. Kim Schrier and Sen. Angela Alsobrooks — urged the CDC to take immediate action on newborn vitamin K shot refusal, calling it a growing public health crisis after reporting found babies were bleeding and dying. The clinical stakes are stark: babies who do not get the shot are 81 times more likely to develop late vitamin K deficiency bleeding, and CDC says 1 in 5 affected infants die.

The Move

• Schrier and Alsobrooks sent a letter to acting CDC director Dr. Jay Bhattacharya pressing the agency to track vitamin K shot refusal, vitamin K deficiency bleeding, and related preventable deaths.

• The letter followed a ProPublica investigation that found no federal or state agency currently tracks refusal rates or downstream harms, even as refusal has risen.

• A national study of more than 5 million births found nonreceipt of vitamin K at birth topped 5% in 2024.

Why It Matters for Care

• Vitamin K is a routine, low-cost injection given at birth to prevent dangerous bleeding in newborns; it is not a vaccine.

• For clinicians, the lack of local and national surveillance means less situational awareness when evaluating a sick infant with possible intracranial or other unexplained bleeding.

• AAP leaders say knowing whether a hospital or region has high refusal rates could speed diagnosis, treatment, and counseling.

Between the Lines

• The push reflects a broader erosion of trust in medical institutions, amplified by online misinformation and spillover from pandemic-era politics.

• Lawmakers and pediatric leaders are also pressing HHS Secretary Robert F. Kennedy Jr. to more clearly endorse the shot, arguing that public silence from top health officials carries consequences.

• This is not just a data gap: advocates want CDC surveillance to support public messaging and a more targeted prevention campaign.

What To Watch

• Whether CDC responds by adding formal tracking or guidance on vitamin K refusal and deficiency bleeding.

• Whether HHS leadership, including Kennedy, publicly and explicitly backs universal newborn vitamin K administration.

• Whether states, hospital systems, or professional societies move first on reporting, dashboards, or clinician education if federal action lags.

Source: ProPublica